Condition
Neoplasm Recurrence clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Neoplasm Recurrence clinical trials that are recruiting, at sites in 3 countries (most in France (1), Guadeloupe (1), Canada (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
Understanding factors affecting prostate cancer progression
This study is trying to find out what factors affect how prostate cancer grows in different people to help improve treatment and prevention for those at higher risk.
-
Evaluating Verity-BCG for treating high-risk non-muscle invasive bladder cancer
This study is testing a new treatment called Verity-BCG to see if it can help people with high-risk bladder cancer stay cancer-free for longer compared to the standard treatment they usually receive.
Related topics
Quick answers
How many Neoplasm Recurrence clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in France (1 trial), Guadeloupe (1 trial), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.